Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Germline variants associated with toxicity to immune checkpoint blockade.

Journal article

Groha S. et al, (2022), Nat Med

Genome-wide association study of leprosy in Malawi and Mali.

Journal article

Gilchrist JJ. et al, (2022), PLoS Pathog, 18

Use of cemiplimab for advanced cutaneous squamous cell carcinoma: first real-world data from a UK perspective - a retrospective review

Conference paper

Nestor LA. et al, (2022), BRITISH JOURNAL OF DERMATOLOGY, 187, 107 - 108

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

Journal article

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

Toward a better understanding of T cells in cancer.

Journal article

Oh DY. et al, (2021), Cancer Cell, 39, 1549 - 1552

Characterising the cfDNA Methylome in Patients with Metastatic Melanoma Treated with Immune Checkpoint Blockade

Conference paper

Cooper R. et al, (2021), JOURNAL OF PATHOLOGY, 255, S40 - S40

Pembrolizumab drug levels and anti-drug antibodies: measurement in two real-world centres

Conference paper

Wilkins L. et al, (2021), EUROPEAN JOURNAL OF IMMUNOLOGY, 51, 122 - 122

EPISPOT: An epigenome-driven approach for detecting and interpreting hotspots in molecular QTL studies.

Journal article

Ruffieux H. et al, (2021), Am J Hum Genet, 108, 983 - 1000

Load More